Boxer Capital, Llc Rain Therapeutics Inc. (RAIN) insider trading activity

Boxer Capital, LLC is of Rain Therapeutics Inc.. Currently has a direct ownership of 1.15 Million shares of RAIN, which is worth approximately $0. The most recent transaction as insider was on May 22, 2023, when has been sold 995,000 shares (Common Stock) at a price of $1.25 per share, resulting in proceeds of $1,243,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.15M

0% 3M change

0% 12M change

Total Value Held $0

Boxer Capital, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 22 2023	SELL Open market or private sale	$1,243,750 $1.25 p/Share	995,000 Reduced 46.34%	1,152,212 Common Stock
Apr 27 2021	BUY Open market or private purchase	$17,425,000 $17.0 p/Share	1,025,000 Added 46.59%	1,175,000 Common Stock
Apr 23 2021	BUY Open market or private purchase	$2,389,500 $15.93 p/Share	150,000 Added 50.0%	150,000 Common Stock

Also insider at

MRTX

Mirati Therapeutics, Inc. Healthcare

ITOS

iTeos Therapeutics, Inc. Healthcare

PMVP

PMV Pharmaceuticals, Inc. Healthcare

TNGX

Tango Therapeutics, Inc. Healthcare

ESPR

Esperion Therapeutics, Inc. Healthcare

> 10% Shareholder

TYRA

Tyra Biosciences, Inc. Healthcare

SLDB

Solid Biosciences Inc. Healthcare

> 10% Shareholder

ODTC

Odonate Therapeutics, Inc. Financial Services

> 10% Shareholder

PAND

Pandion Therapeutics, Inc.

> 10% Shareholder

BCL